Alcidion Group Limited · ASX:ALC
Alcidion — Shareholder Meeting (November 2019)
17 slides from Alcidion's shareholder meeting presentation, Nov 14, 2019
Slide 1: Investor Presentation: Leading the digital transformation of healthcare
For personal use only Investor Presentation Leading the digital transformation of healthcare Kate Quirke, Group Managing Director Annual General Meeting – 14 November 2019 1
Slide 2: Challenges facing healthcare providers
Challenges facing healthcare providers For personal use only Healthcare providers must adopt technology to improve patient outcomes and deliver efficiencies to meet demand Big single solution EMR is not the answer - care team productivity can drop by 20-30% Demographic Industry Rising Cost Trends Ch
Slide 3: Better lives by transforming healthcare delivery through smart technology
Better lives by transforming healthcare For personal use only delivery through smart technology 30K 215 42 • Highly differentiated platform providing Beds using our technology Hospitals across the UK, Australia, New Healthcare organisations smart infrastructure for healthcare Zealand transforming he
Slide 4: Uniquely placed to transform healthcare delivery
Uniquely placed to transform For personal use only healthcare delivery • Miya Precision is an innovative events driven platform • Adds real value to existing investment in Electronic Medical Records (EMR) • Better decisions engineering the risk out of healthcare, pushed to the point of care • Busine
Slide 5: Alcidion's growth since listing in 2016
Alcidion’s growth since listing in 2016 For personal use only Two acquisitions delivered a diversified product platform, enhanced IT and sales capability, significantly improving the Company’s financial position FEBRUARY 2018 JULY 2018 JULY 2018 MARCH 2019 JULY 2019 SEPTEMBER 2019 Alcidion completes
Slide 6: Product demonstration
For personal use only Product demonstration
Slide 7: Our opportunity to accelerate growth
For personal use only Our opportunity to accelerate growth Commercial in Confidence
Slide 8: Capitalising on the Growth Opportunity
Capitalising on the Growth Opportunity For personal use only The Growth Opportunity • Significant global market opportunity - digital patient data driving demand • Regulatory environment leading technology adoption in healthcare • A leading-edge technology suite and differentiated product offering •
Slide 9: Growth Strategy underpinned by additional $16.2m capital
Growth Strategy underpinned by additional $16.2m capital For personal use only Use of funds Geographical expansion Accelerate the ANZ Business Accelerating UK growth • Strengthen sales and marketing capabilities to • UK is Alcidion’s largest addressable market demonstrate value of our platform to ex
Slide 10: Australia – ready to expand
Australia – ready to expand For personal use only Current state of play Alcidion today Global Market potential - 5 years • EMR penetration in public sector is Opportunity to increase share of beds high: 60-70% of hospitals (beds) covered by part or all EMR • Hospital spending rising by 4.2% per annu
Slide 11: UK – our largest current market
UK – our largest current market For personal use only Current state of play Alcidion today Global Market potential - 5 years • Early adopter of new technology Opportunity to increase share of beds within Europe, less EMR penetration, hybrid approach including best of breed NHSX - government leading
Slide 12: NZ - strong existing presence provides future potential to upsell
NZ - strong existing presence provides future potential to upsell For personal use only Current state of play Alcidion today Global Market potential - 5 years • Best of breed more commonly used Opportunity to increase share of beds over integrated EMR • Patientrack clear market leader for patient ob
Slide 13: Opportunity in additional markets
Opportunity in additional markets For personal use only Number of Hospitals by Region (2016) • Similar drivers for adoption exist • Shift to digitalisation still at an early stage 700,000 in many markets • Currently analysing markets with earliest potential • Canada, Singapore, South Africa, Germany
Slide 14: Operational Update
Operational Update For personal use only • Delivery / implementation on major projects Dartford and Gravesham NHS Trust – Phase 1 of strategic project (Patientrack) – now live Referral service directory for Queensland Health – now live Alfred Hospital data analytics platform delivered • Sales force
Slide 15: The opportunity ahead for Alcidion
The opportunity ahead for Alcidion For personal use only • Positioned to capture large market opportunity at the right time, as healthcare undergoes digital transformation • Differentiated offering and unique tech platform – delivering solutions for a range of hospital needs with strong cross-sellin
Slide 16: Contacts
Contacts For personal use only Kyahn Williamson Head of Investor Communication WE Communications Kwilliamson@we-worldwide.com +61 401 018 828 16
Slide 17: Disclaimer
Disclaimer For personal use only This presentation has been prepared by Alcidion Group Limited (‘Alcidion’). The information in this presentation is of a general nature and does not purport to be complete, nor does it contain all the information which would be required in a prospectus prepared in ac